Quoin Pharmaceuticals, Ltd. (QNRX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -4.87M | -5.08M | -2.23M | -3.69M | -2.59M | -2.24M | -2.18M | -2.01M | -1.43M | -3.22M | -1.32M | -1.57M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -87.69% | -127.2% | -2.12% | -83.66% | -80.86% | 30.62% | -64.91% | -27.62% | 17.87% | -40.81% | 42.38% | 26.9% |
| Net Income | -5M | -15.79B | -3.95M | -3.7M | -3.81M | -2.31M | -2.35M | -1.97M | -2.33M | -2.05M | -1.93M | -2.11M |
| Depreciation & Amortization | 25K | 99.92M | 25K | 25K | 25K | 25K | 25K | 25K | 25K | 25.67K | 26.01K | 26.01K |
| Stock-Based Compensation | 444.52K | 1.15B | 182K | 321K | 360.36K | 325.89K | 313K | 682K | 306.31K | 300.2K | 268.5K | 264K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -111.15K | 14.54B | 1.43M | -591.56K | -67.06K | 319.06K | -544.17K | -664.3K | 545.46K | -1.1M | -138.71K | 79.53K |
| Working Capital Changes | -229.56K | -923.48K | 86.28K | 255.17K | 899.71K | -595.2K | 376.76K | -75.79K | 16.13K | -398.6K | 449.35K | 164.68K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -200.9K | -259.36K | 0 | 0 | 674.68K | 0 | 0 | 0 | 0 | 0 | 286.21K | 0 |
| Cash from Investing | 4.12M | -11.35M | 2.54M | 1.68M | 2.77M | -3.18M | 2.6M | 3.15M | -4.47M | 2.64M | 821 | 3.04M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 5.1M | -6.36B | 2.54M | 1.68M | -172.96K | -3.18M | 2.6M | 3.15M | -4.47M | 2.64M | 0 | 3.04M |
| Cash from Financing | 55.98K | 18.44M | -150K | -150K | 22.96K | 5.92M | -149.89K | -136.28K | 5.33M | -182.58K | -275K | -75K |
| Debt Issued (Net) | 0 | 0 | -150K | -150K | -150K | -150K | -150K | -150K | -150K | -150K | -275K | -75K |
| Equity Issued (Net) | 205.42K | 18.59M | 0 | 0 | 172.06K | 0 | 0 | 0 | 0 | 0 | -13.52K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -149.44K | -151.53K | 0 | 0 | 899 | 6.07M | 108 | 13.72K | 5.48M | -32.58K | 13.52K | 0 |
| Net Change in Cash | -693.57K | 1.99M | 162.41K | -2.15M | 198.78K | 506.59K | 271.62K | 1.01M | -567.67K | -762.23K | -1.6M | 1.39M |
| Free Cash Flow | -4.87M | -5.08M | -2.23M | -3.69M | -2.59M | -2.24M | -2.18M | -2.01M | -1.43M | -3.22M | -1.32M | -1.57M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -87.69% | -127.2% | -2.12% | -83.66% | -80.86% | 30.62% | -64.91% | -27.62% | 17.87% | -40.81% | 42.38% | 26.9% |
| FCF per Share | -2.48 | -3.39 | -3.78 | -6.27 | -4.42 | -11.99 | -0.44 | -0.40 | -0.68 | -3.27 | -1.34 | -1.59 |
| FCF Conversion (FCF/Net Income) | 0.98x | 1.17x | 0.56x | 1.00x | 0.68x | 0.97x | 0.93x | 1.02x | 0.62x | 1.57x | 0.69x | 0.75x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |